Home > Listed Companies Info. > Main Board Companies

:::

:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

Code:

Industry:

Local/Foreign Company:

6785 Alar

中文

Company Profile

Chairman

CEO

Spokesperson

Tel

Address

Date of Listing (Regular)

Charles Lin

Yung-Shun Wen

04-24637115

5F., No.32, Keya Rd., Daya Dist.Taichung City, Taiwan (R.O.C.)

2024/01/24

Industry

Main Business

Biotechnology and Medical Care

We focus on developing long-acting release drug products for CNS disorders and chronic diseases, which mainly include opioid use disorder, chronic pain, and major depressive disorder. These chronic diseases not only cause long-term burdens to the patients and their families but also consume huge social costs. Long-acting release product is a solution to improve medical quality, enhance patient’s compliance, and increase drug adherence. The unique long-acting release platform developed by Alar is different from the current long-acting technologies. Drug products developed by our platform have distinctive characteristics such as low viscosity, small injection volume, and smooth drug release profile with fewer side effects, which provide a better medical choice for patients. We believe that with the corporate philosophy of improving medical quality, it will reach the milestones of excellence in developing long-acting drug products.

Shr. Vol.	Highest	Lowest	Closed	Change	Transaction	TurnOver(%)	long margin balance (1,000shr.)	Short margin balance (1,000shr.)
Market Information ( 2024/04/30 )
511.534	285.00	270.00	273.50	-5.50	707	.00	N/A	N/A
Trading method	Fun purchase price or securities pneeded on T day	Announcement of Irregularity (2024/04/30)	TPEx measures adopted (2024/04/30)		With warrants	Can be shorted or margined?	Detail
Normal	N	N	N		Y	N	Today	History

Financial Reports
Cash Flows	Items
	Items	Amount (NT$ thousand)
	Cash flows from operating activities
	Cash flows from investing activities
	Cash flows from financing activities
Balance Sheets	Current assets
	Non-current assets
	Total assets
	Current liabilities
	Non-current liabilities
	Total liabilities
	Share capital
	Capital surplus
	Retained earnings
	Other equity interest
	Treasury shares
	Total equity attributable to owners of parent
	Non-controlling interests
	Total equity
	Book Value per share(NT$)
Comprehensive Income	Operating revenue
	Operating costs
	Gross profit from operations
	Operating expenses
	Net other income (expenses)
	Net operating income
	Non-operating income and expenses
	Profit before tax
	Tax expense
	Profit from continuing operations
	Profit from discontinued operations
	Profit
	Other comprehensive income
	Comprehensive income
	Basic earnings per share

Auditor's report on latest financial statements： auditor's report：

More detail:MOPS。

Foreign issuers’ information is disclosed in consolidated statements.

TOP

TPEx

Listed Companies

General Stock Board Listed Company Profile